RNXT insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| Stark Richard Director · RenovoRx, Inc. | RNXT RenovoRx, Inc. | Equity grant or awardFiling detailsSEC transaction code A Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 128824 · The option vests and becomes exercisable in 36 equal monthly installments on the 18th day of each month beginning December 18, 2026, subject to the Reporting Person's continued service, and vests in full upon a change in control of the Issuer. | 2026-11-18 | 2026-11-20 | 128,824 shares/units | SEC 4 | Follow |
| Agah Ramtin Executive Chairman and CMO · Director · RenovoRx, Inc. | RNXT RenovoRx, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 848460 · SEC code covers open-market or private transactions · Reflects open market purchases of the Issuer's securities. · Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.925 to $0.9299. | 2026-11-16 | 2026-11-17 | ≈ $46,485.00 50,000 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.